About The Position

We are sharing a specialised part-time consulting opportunity for experienced payer and market access professionals with deep expertise in gross-to-net modelling, rebates, formulary strategy, pricing and reimbursement, and managed markets within the US pharmaceutical sector. This role supports an expert evaluation initiative focused on commercial medicines and drug-development programmes. Selected professionals will develop and critique evaluation rubrics, pressure-test gross-to-net and formulary assumptions, and assess whether coverage, rebate, and tiering strategies accurately reflect real-world payer behaviour across different drug classes.

Requirements

  • At least 5 years of professional experience in market access, pricing and reimbursement, managed markets, or a closely related pharmaceutical function
  • Hands-on experience with gross-to-net modelling and analysis
  • Strong knowledge of pharmaceutical rebates and contracting dynamics
  • Experience evaluating formulary placement and tiering by drug class
  • Deep understanding of US payer behaviour and reimbursement structures
  • Familiarity with biotech and pharmaceutical development programmes
  • Strong commercial judgment and analytical reasoning
  • Excellent written communication and attention to detail
  • Current US-based professional experience

Nice To Haves

  • Experience working directly with health plans, PBMs, or payer organisations
  • Background in pharmaceutical pricing strategy
  • Experience with contracting and rebate negotiations
  • Familiarity with Medicare, Medicaid, and commercial payer dynamics
  • Experience evaluating launch access strategies
  • Knowledge of utilisation management and formulary decision-making
  • Experience advising biotechnology or pharmaceutical leadership teams
  • Prior experience with structured expert review, rubric development, or AI evaluation

Responsibilities

  • Evaluate market access strategies for commercial and development-stage pharmaceutical products
  • Assess payer behaviour across different therapeutic areas and drug classes
  • Review assumptions involving coverage, access restrictions, formulary placement, and reimbursement
  • Apply practical US managed-markets expertise to commercial analyses
  • Identify assumptions that are inconsistent with real-world payer decision-making
  • Develop and pressure-test gross-to-net assumptions
  • Evaluate rebate expectations across different drug classes and payer segments
  • Assess whether discounting and concession assumptions are commercially realistic
  • Review the relationship between list price, rebates, access, and net revenue
  • Identify unsupported or internally inconsistent gross-to-net assumptions
  • Evaluate formulary-tier assumptions and expected product positioning
  • Assess potential preferred, non-preferred, restricted, or excluded formulary status
  • Review assumptions involving prior authorisation, step therapy, and other utilisation-management mechanisms
  • Analyse how competitive dynamics may influence formulary access
  • Assess whether proposed tiering strategies reflect realistic payer incentives
  • Create structured evaluation rubrics for pharmaceutical market access analysis
  • Critique existing rubrics for completeness, realism, and commercial relevance
  • Define criteria reflecting experienced payer and market access judgment
  • Identify missing considerations or weak assumptions in analytical frameworks
  • Provide clear written reasoning supporting evaluation decisions

Benefits

  • Competitive rates between $170–$195 per hour depending on expertise and project scope
  • Weekly payments via Stripe or Wise
  • Potential for recurring or expanded engagements
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service